Novavax
Patents, Design & Utilities

Last updated:

List of all Novavax patents 24 in total

Status Patent
Application
Utility: METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE External link
Filling date: 6 Sep 2025 Issue date: 7 Jul 2022
Grant
Utility: Vaccine compositions having improved stability and immunogenicity External link
Filling date: 6 Sep 2025 Issue date: 21 Jun 2022
Application
Utility: METHODS FOR PREVENTING DISEASE OR DISORDER CAUSED BY RSV INFECTION External link
Filling date: 6 Sep 2025 Issue date: 5 May 2022
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 28 Apr 2022
Grant
Utility: Multivalent influenza nanoparticle vaccines External link
Filling date: 6 Sep 2025 Issue date: 22 Mar 2022
Application
Utility: MULTIVALENT INFLUENZA NANOPARTICLE VACCINES External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2022
Grant
Utility: Coronavirus vaccine formulations External link
Filling date: 6 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Vaccine compositions having improved stability and immunogenicity External link
Filling date: 6 Sep 2025 Issue date: 22 Feb 2022
Grant
Utility: Methods and compositions for inducing immune responses against Clostridium difficile External link
Filling date: 6 Sep 2025 Issue date: 21 Sep 2021
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Application
Utility: CORONAVIRUS VACCINE FORMULATIONS External link
Filling date: 6 Sep 2025 Issue date: 29 Jul 2021
Grant
Utility: Modified RSV F proteins and methods of their use External link
Filling date: 6 Sep 2025 Issue date: 6 Jul 2021
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE External link
Filling date: 6 Sep 2025 Issue date: 13 May 2021
Grant
Utility: Coronavirus vaccine formulations External link
Filling date: 6 Sep 2025 Issue date: 23 Mar 2021
Grant
Utility: Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods External link
Filling date: 6 Sep 2025 Issue date: 25 Aug 2020
Grant
Utility: Functional influenza virus like particles (VLPs) External link
Filling date: 6 Sep 2025 Issue date: 4 Aug 2020
Application
Utility: VACCINE COMPOSITIONS HAVING IMPROVED STABILITY AND IMMUNOGENICITY External link
Filling date: 6 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: METHODS AND COMPOSITIONS FOR INDUCING IMMUNE RESPONSES AGAINST CLOSTRIDIUM DIFFICILE External link
Filling date: 6 Sep 2025 Issue date: 19 Mar 2020
Grant
Utility: Functional influenza virus-like particles (VLPS) External link
Filling date: 6 Sep 2025 Issue date: 4 Feb 2020
Application
Utility: MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE External link
Filling date: 6 Sep 2025 Issue date: 30 Jan 2020
Grant
Utility: Highly efficient influenza matrix (M1) proteins External link
Filling date: 6 Sep 2025 Issue date: 28 Jan 2020
Application
Utility: MULTIVALENT INFLUENZA NANOPARTICLE VACCINES External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019
Application
Utility: FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPs) External link
Filling date: 6 Sep 2025 Issue date: 17 Oct 2019
Grant
Utility: Vaccine compositions having improved stability and immunogenicity External link
Filling date: 6 Sep 2025 Issue date: 1 Oct 2019

Showing 1 to 24 of 24 patents.